Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference48 articles.
1. An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation;Aikawa;Inflammation Res.,2002
2. T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis;Du;Arthritis Res. Ther.,2008
3. T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro;Du;Int. Immunopharmacol.,2012
4. Efficacy and safety evaluation of a combination of iguratimod and methotrexate therapy for active rheumatoid arthritis patients: a randomized controlled trial;Duan;Clin. Rheumatol,2015
5. The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab;Ebina;Mod. Rheumatol.,2019
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Transdermal delivery of iguratimod and colchicine ethosome by dissolving microneedle patch for the treatment of recurrent gout;Colloids and Surfaces B: Biointerfaces;2024-10
2. The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis;Chinese Medical Journal;2024-07-26
3. Efficacy and safety of iguratimod combined with celecoxib in active axial spondyloarthritis: a randomized, double-blind, placebo-controlled study;Scandinavian Journal of Rheumatology;2024-06-04
4. Simultaneous determination of iguratimod and its metabolite in rat plasma using a UPLC-MS/MS method: Application for drug-drug interaction;Journal of Pharmaceutical and Biomedical Analysis;2024-06
5. Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways;Biomedicine & Pharmacotherapy;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3